%0 Journal Article
%T Prognostic role of a new inflammatory index with neutrophil-to-lymphocyte ratio and lactate dehydrogenase (CII: Colon Inflammatory Index) in patients with metastatic colorectal cancer: results from the randomized Italian Trial in Advanced Colorectal Cancer£¿(ITACa) study
%A Alessandro Passardi
%A Andrea Casadei-Gardini
%A Andrea Spallanzani
%A Caterina Accettura
%A Emanuela Scarpi
%A Fabio Gelsomino
%A Giorgia Marisi
%A Giovanni Luca Frassineti
%A Ilaria Bernardini
%A Jody Corbelli
%A Maria Angela Palladino
%A Martina Valgiusti
%A Paola Ulivi
%A Silvia Ruscelli
%J Archive of "Cancer Management and Research".
%D 2019
%R 10.2147/CMAR.S198651
%X Aim: The aim of this study was to investigate the role of a new inflammatory index (Colon Inflammatory Index [CII]) as a predictor of prognosis and treatment efficacy in patients with metastatic colorectal cancer (mCRC) enrolled in the prospective multicenter randomized ITACa (Italian Trial in Advanced Colorectal Cancer) trial to receive first-line chemotherapy (CT)+ bevacizumab or CT alone
%K metastatic colorectal cancer
%K bevacizumab
%K first-line
%K prognosis
%K lactate dehydrogenase
%K neutrophil-to-lymphocyte ratio
%U https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6522652/